LRRK2 and Parkinson disease: Yet, dual mutation carriers (GBA-LRRK2-PD) have been found to have a milder disease phenotype compared to GBA-PD89–91, raising the possibility of a protective mechanism for LRRK2 on the GBA disease phenotype.